Drug Type Small molecule drug |
Synonyms PTD 988, PTD988 |
Target |
Action antagonists |
Mechanism GPR17 antagonists(G protein-coupled receptor 17 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Nervous System Diseases | Preclinical | United Kingdom | 01 Jan 2025 |





